Month: April 2024
The HPV 16+ cancer market size is anticipated to increase due to an increase in the research and development programs related to HPV 16+ cancer in recent years. Future research requires focusing on elucidating HPV 16+ cancer’s natural history and searching for an appropriate treatment…
The growth of the giant-cell arteritis market is expected to be mainly driven by the growing geriatric population, the rise in the prevalence of cardiovascular disorders, technological advancements in the healthcare industry, and others. LAS VEGAS, April 8, 2024 /PRNewswire/ –…
NEW YORK, April 8, 2024 /PRNewswire/ — The global apheresis devices market size is estimated to grow by USD 1.59 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 8.45% during the forecast period. Apheresis devices are utilized for separating…
Robert A. Copeland, Chief Scientific Officer, to provide major symposium presentation on inhibition of key RNA-modifying enzymes as precision cancer therapeutics Preclinical data validate DHX9 as a new target in breast cancer and other solid tumors with loss-of-function mutations in the…
-GV20-0251 is the first ever AI-designed antibody against an AI-predicated target to advance into the clinic- CAMBRIDGE, Mass., April 8, 2024 /PRNewswire/ — GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation…
Rice University hosts world’s largest and richest student startup competition HOUSTON, April 8, 2024 /PRNewswire/ — Ice cream company Protein Pints took home the grand prize at the 2024 Rice Business Plan Competition (RBPC) April 6 as the best student ventures from top universities…